英国的新冠病毒人体挑战研究。 - Suppr

Suppr

超能文献

COVID-19 human challenge studies in the UK.

作者信息

Kirby Tony

出版信息

Lancet Respir Med. 2020 Dec;8(12):e96. doi: 10.1016/S2213-2600(20)30518-X. Epub 2020 Oct 30.

DOI:10.1016/S2213-2600(20)30518-X

PMID:33137284

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7831781/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2668/7831781/4d3affabcbbc/fx1_lrg.jpg

相似文献

COVID-19 human challenge studies in the UK.

Lancet Respir Med. 2020 Dec;8(12):e96. doi: 10.1016/S2213-2600(20)30518-X. Epub 2020 Oct 30.

Status of vaccine development for COVID-19.

Br J Community Nurs. 2020 Dec 2;25(12):620-621. doi: 10.12968/bjcn.2020.25.12.620.

COVID-19 vaccines: ethical framework concerning human challenge studies.

Daru. 2020 Dec;28(2):807-812. doi: 10.1007/s40199-020-00371-8. Epub 2020 Aug 27.

UK science advisers: publish evidence behind COVID vaccine changes.

Nature. 2021 Jan;589(7841):169-170. doi: 10.1038/d41586-021-00045-8.

Messengers of hope.

Nat Biotechnol. 2021 Jan;39(1):1. doi: 10.1038/s41587-020-00807-1.

The UK has approved a COVID vaccine - here's what scientists now want to know.

Nature. 2020 Dec;588(7837):205-206. doi: 10.1038/d41586-020-03441-8.

Immunity to glycan α-Gal and possibilities for the control of COVID-19.

Immunotherapy. 2021 Feb;13(3):185-188. doi: 10.2217/imt-2020-0247. Epub 2020 Dec 14.

Novavax offers first evidence that COVID vaccines protect people against variants.

Nature. 2021 Feb;590(7844):17. doi: 10.1038/d41586-021-00268-9.

A COVID-19 vaccine-dare to dream.

Br J Community Nurs. 2020 Dec 2;25(12):2-7. doi: 10.12968/bjcn.2020.25.12.598.

Why Oxford's positive COVID vaccine results are puzzling scientists.

Nature. 2020 Dec;588(7836):16-18. doi: 10.1038/d41586-020-03326-w.

引用本文的文献

Ethical acceptability of human challenge trials: Consultation with the US public and with research personnel.

PLoS One. 2024 Oct 22;19(10):e0307808. doi: 10.1371/journal.pone.0307808. eCollection 2024.

Safety risks and ethical governance of biomedical applications of synthetic biology.

Front Bioeng Biotechnol. 2023 Oct 24;11:1292029. doi: 10.3389/fbioe.2023.1292029. eCollection 2023.

Novel Influenza Vaccines: From Research and Development (R&D) Challenges to Regulatory Responses.

Vaccines (Basel). 2023 Oct 9;11(10):1573. doi: 10.3390/vaccines11101573.

Early SARS-CoV-2 dynamics and immune responses in unvaccinated participants of an intensely sampled longitudinal surveillance study.

Commun Med (Lond). 2022 Oct 11;2:129. doi: 10.1038/s43856-022-00195-4. eCollection 2022.

A practical approach to SARS-CoV-2 testing in a pre and post-vaccination era.

J Clin Virol Plus. 2021 Dec;1(4):100044. doi: 10.1016/j.jcvp.2021.100044. Epub 2021 Oct 8.

Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection).

Clin Lab Med. 2022 Mar;42(1):111-128. doi: 10.1016/j.cll.2021.10.008. Epub 2021 Nov 3.

SARS-CoV-2 viability on sports equipment is limited, and dependent on material composition.

Sci Rep. 2022 Jan 26;12(1):1416. doi: 10.1038/s41598-022-05515-1.

Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission.

Viruses. 2021 Sep 24;13(10):1921. doi: 10.3390/v13101921.

Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?

Lancet Respir Med. 2021 Dec;9(12):1450-1466. doi: 10.1016/S2213-2600(21)00407-0. Epub 2021 Oct 21.

Airborne SARS-CoV-2 surveillance in hospital environment using high-flowrate air samplers and its comparison to surface sampling.

Indoor Air. 2022 Jan;32(1):e12930. doi: 10.1111/ina.12930. Epub 2021 Sep 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

COVID-19 human challenge studies in the UK.

Lancet Respir Med. 2020 Dec;8(12):e96. doi: 10.1016/S2213-2600(20)30518-X. Epub 2020 Oct 30.

Status of vaccine development for COVID-19.

Br J Community Nurs. 2020 Dec 2;25(12):620-621. doi: 10.12968/bjcn.2020.25.12.620.

COVID-19 vaccines: ethical framework concerning human challenge studies.

Daru. 2020 Dec;28(2):807-812. doi: 10.1007/s40199-020-00371-8. Epub 2020 Aug 27.

UK science advisers: publish evidence behind COVID vaccine changes.

Nature. 2021 Jan;589(7841):169-170. doi: 10.1038/d41586-021-00045-8.

Messengers of hope.

Nat Biotechnol. 2021 Jan;39(1):1. doi: 10.1038/s41587-020-00807-1.

The UK has approved a COVID vaccine - here's what scientists now want to know.

Nature. 2020 Dec;588(7837):205-206. doi: 10.1038/d41586-020-03441-8.

Immunity to glycan α-Gal and possibilities for the control of COVID-19.

Immunotherapy. 2021 Feb;13(3):185-188. doi: 10.2217/imt-2020-0247. Epub 2020 Dec 14.

Novavax offers first evidence that COVID vaccines protect people against variants.

Nature. 2021 Feb;590(7844):17. doi: 10.1038/d41586-021-00268-9.

A COVID-19 vaccine-dare to dream.

Br J Community Nurs. 2020 Dec 2;25(12):2-7. doi: 10.12968/bjcn.2020.25.12.598.

Why Oxford's positive COVID vaccine results are puzzling scientists.

Nature. 2020 Dec;588(7836):16-18. doi: 10.1038/d41586-020-03326-w.

引用本文的文献

Ethical acceptability of human challenge trials: Consultation with the US public and with research personnel.

PLoS One. 2024 Oct 22;19(10):e0307808. doi: 10.1371/journal.pone.0307808. eCollection 2024.

Safety risks and ethical governance of biomedical applications of synthetic biology.

Front Bioeng Biotechnol. 2023 Oct 24;11:1292029. doi: 10.3389/fbioe.2023.1292029. eCollection 2023.

Novel Influenza Vaccines: From Research and Development (R&D) Challenges to Regulatory Responses.

Vaccines (Basel). 2023 Oct 9;11(10):1573. doi: 10.3390/vaccines11101573.

Early SARS-CoV-2 dynamics and immune responses in unvaccinated participants of an intensely sampled longitudinal surveillance study.

Commun Med (Lond). 2022 Oct 11;2:129. doi: 10.1038/s43856-022-00195-4. eCollection 2022.

A practical approach to SARS-CoV-2 testing in a pre and post-vaccination era.

J Clin Virol Plus. 2021 Dec;1(4):100044. doi: 10.1016/j.jcvp.2021.100044. Epub 2021 Oct 8.

Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection).

Clin Lab Med. 2022 Mar;42(1):111-128. doi: 10.1016/j.cll.2021.10.008. Epub 2021 Nov 3.

SARS-CoV-2 viability on sports equipment is limited, and dependent on material composition.

Sci Rep. 2022 Jan 26;12(1):1416. doi: 10.1038/s41598-022-05515-1.

Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission.

Viruses. 2021 Sep 24;13(10):1921. doi: 10.3390/v13101921.

Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?

Lancet Respir Med. 2021 Dec;9(12):1450-1466. doi: 10.1016/S2213-2600(21)00407-0. Epub 2021 Oct 21.

Airborne SARS-CoV-2 surveillance in hospital environment using high-flowrate air samplers and its comparison to surface sampling.

Indoor Air. 2022 Jan;32(1):e12930. doi: 10.1111/ina.12930. Epub 2021 Sep 14.